04153nam a22005535i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001300172072001600185072002300201072001500224245013300239250001800372264006900390300006500459336002600524337002600550338003600576347002400612505054700636520173201183650002202915650001502937650002102952650002002973650002302993650002403016650002203040650001503062650002103077650002003098650002303118650002203141700009003163700008703253710003403340773002603374776003603400776003603436776003603472856004603508912001403554912001403568999001703582978-3-031-54196-4DE-He21320251030113032.0cr nn 008mamaa240829s2024    sz |    s    |||| 0|eng d  a97830315419649978-3-031-54196-47 a10.1007/978-3-031-54196-42doi 4aR895-920 7aMMN2bicssc 7aMED0800002bisacsh 7aMKR2thema10aRadiopharmaceuticalsh[electronic resource] :bA Guide to PET/CT and PET/MRI /cedited by Ferdinando Calabria, Orazio Schillaci.  a3rd ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024.  aX, 330 p. 232 illus., 216 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 a1. 18F-FDG -- 2. 18F-DOPA -- 3. The lipogenesis pathway: radiolabeled Choline -- 4. 18F-FET -- 5. 18F-NaF -- 6. Somatostatin receptor analogs (68Ga-DOTATOC, 68Ga-DOTANOC, 68Ga-DOTATATE) -- 7. 7 64Cu-Radiopharmaceuticals -- 8. Amyloid Imaging -- 9. PET myocardial perfusion imaging: 82Rb -- 10. The Bone Pathway: 223Ra-Dichloride -- 11. 11C-Methionine -- 12. 68Ga-PSMA -- 13. PET biomarkers for Tau Pathology -- 14. 18F-Fluciclovine -- 15. 18F-FAPI -- 16. 18F-FES -- 17. 68Ga-Pentixafor -- 18. 18F-FLT -- 19. Neuroinflammation -- 20. 18F-FAZA.  aThe book is a practical and concise guide to PET tracers actually useful for PET/CT and PET/MR imaging. Gaining knowledge on radiopharmaceuticals is often difficult, since their features can be only found in single original journal articles.This book aims to present to the reader, in one single place, clinical features, indications and future trends for PET imaging with a large amount of tracers. While 18F-FDG still remains the miliar stone across PET tracer, new emerging fields of application of PET imaging are consolidated by using disease specific tracers in specific clinical settings. Each chapter is focused on a single tracer or on a group of similar tracers. The basis and structure of the chapters is the same throughout the book: essential information on synthesis and in vivo distribution of a tracer, clinical cases, eloquently showing clinical indications and usefulness, future trends, scientific literature. Featuring over 30 radiopharmaceuticals and 240 clinical cases, the 3rd edition has been enriched with additional chapters on the clinical indications and/or common pitfalls for 18F-fluciclovine PET/CT in prostate cancer imaging and for 18F-MISO in PET tumor hypoxia imaging, as well as applications and future directions for 18F-FES and other PET radiopharmaceuticals. All other chapters of the previous edition have been revised and updated, in particular those chapters covering 18F-DOPA, radiolabeled choline, and 18F-NAF, due to emerging clinical applications for these tracers, 18F-choline for imaging of parathyroid adenoma and 18F-DOPA for restaging of medullary thyroid cancer. The book will be an invaluable guide for professionals and residents in nuclear medicine, radiology, oncology. . 0aNuclear medicine. 0aRadiology. 0aOncology.970760 0aUrology.969549 0aHematology.976927 0aNeurology .96681614aNuclear Medicine.24aRadiology.24aOncology.97076024aUrology.96954924aHematology.97692724aNeurology.9668161 aCalabria, Ferdinando.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9839891 aSchillaci, Orazio.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9839902 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303154195708iPrinted edition:z978303154197108iPrinted edition:z978303154198840uhttps://doi.org/10.1007/978-3-031-54196-4  aZDB-2-SME  aZDB-2-SXM  c63231d63231